March 21, 2020
From the event website:
Date & Location
Saturday, March 21, 2020, 7:00 AM – 5:30 PM, Paul Brest Hall- Munger Bldg 4, Stanford, CA
We find ourselves at a fascinating time – pushing the envelope on psychiatric treatments, including psychedelic-assisted psychotherapy, rapid-acting agents, and more. As we move forward, this conference emphasizes the need for high-quality research, scientific/empirical evidence, and safeguards against adverse effects and outcomes. Additionally, we need the scholarly efforts of all relevant fields and interprofessional collaborations. This CME activity will cover emerging treatment areas in psychiatry including the related basic science, benefits, risks and clinical trial evidence.
Emergency Medicine & Trauma, Family Medicine & Community Health, Internal Medicine, Oncology, Pain Medicine, Psychiatry & Behavioral Sciences
At the conclusion of this activity, participants should be able to:
- Evaluate emerging therapeutics in psychiatry
- Analyze the risk, benefits, and clinical trial evidence relating to emerging therapeutics in psychiatry
- Determine the clinical application of emerging therapeutics in psychiatry and consider FDA approved and off label uses
Registration includes online course materials, certificate of participation, breakfast and lunch.
Early Bird Rate:
Physician/Clinical Psychologist – $395
Nurse/AHP/Other – $345
Physician/Clinical Psychologist – $495
Nurse/AHP/Other – $445
Tuition may be paid by Visa, MasterCard or check. Your email address is used for critical information, including registration confirmation, evaluation, and certificate. Be sure to include an email address that you check frequently. If you prefer to pay by phone or check, please contact the Stanford Center for CME at (650) 497-8554 for assistance.
STAP-eligible employees can use STAP funds towards the registration fees for this activity. Complete the STAP Reimbursement Request Form and submit to your department administrator.
The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Stanford University School of Medicine designates this live activity for a maximum of 8.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The California Board of Registered Nursing recognizes that Continuing Medical Education (CME) is acceptable for meeting RN continuing education requirements as long as the course is certified for AMA PRA Category 1 CreditsTM (rn.ca.gov). Nurses will receive a Certificate of Participation following this activity that may be used for license renewal.